Three-Dimensional Electroanatomical Voltage Mapping and Histologic Evaluation of Myocardial Substrate in Right Ventricular Outflow Tract Tachycardia  by Corrado, Domenico et al.
T
c
(
m
g
(
b
F
D
w
P
r
a
Journal of the American College of Cardiology Vol. 51, No. 7, 2008
© 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00
PHeart Rhythm Disorders
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Padua, Italy
Objectives We tested whether 3-dimensional electroanatomical voltage mapping (EVM) may help in the differential diagno-
sis between idiopathic right ventricular outflow tract (RVOT) tachycardia and arrhythmogenic right ventricular
cardiomyopathy/dysplasia (ARVC/D).
Background Right ventricular EVM has been demonstrated to reliably identify low-voltage regions (“electroanatomical scar”),
which in patients with ARVC/D correspond to areas of fibrofatty myocardial replacement.
Methods The study population comprised 27 patients (15 men and 12 women, age 33.9  8 years) with RVOT tachycar-
dia and no echocardiographic/angiographic evidence of right ventricular (RV) dilation/dysfunction, who under-
went EVM and endomyocardial biopsy (EMB) for characterization of ventricular tachycardia (VT) substrate before
catheter ablation.
Results Electroanatomical voltage mapping was normal in 20 of 27 patients (74%, group A), with electrogram voltage
1.5 mV throughout the RV. The other 7 patients (26%, group B) showed 1 (1.4  07) RV electroanatomical
scar area(s) (bipolar voltage 0.5 mV) that correlated with fibrofatty myocardial replacement at EMB (p 
0.001). Clinical predictors of RV scar were right precordial QRS prolongation (p  0.001) and VT inducibility
(p  0.001). Catheter ablation successfully eliminated VT in 18 of 20 patients (90%). During a follow-up of 41 
8 months, 3 of 7 patients (43%) from group B received an implantable defibrillator because of life-threatening
ventricular arrhythmias, compared with no patients from group A (p  0.016).
Conclusions An early/minor form of ARVC/D may mimic idiopathic RVOT tachycardia. Electroanatomical voltage mapping is
able to identify RVOT tachycardia due to concealed ARVC/D by detecting RVOT electroanatomical scars that cor-
relate with fibrofatty myocardial replacement at EMB and predispose to sudden arrhythmic death. (J Am Coll
Cardiol 2008;51:731–9) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.11.027s
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T
che right ventricular outflow tract (RVOT) is the most
ommon source of nonischemic ventricular tachycardia
VT). Right ventricular outflow tract tachycardia is com-
only due to idiopathic RVOT tachycardia or arrhythmo-
enic right ventricular cardiomyopathy/dysplasia (ARVC/D)
1). Idiopathic RVOT tachycardia is a nonfamilial and
enign condition that occurs in young individuals without
rom the Departments of *Cardiac, Thoracic, and Vascular Sciences, and †Medical-
iagnostic Sciences, University of Padua Medical School, Padua, Italy. This study
as supported by the Ministry of Health, Rome, Italy; the CARIPARO Foundation,
adua, Italy; the Veneto Region, Venice, Italy; and the European Community
esearch contract # QLG1 CT-2000 01091.e
Manuscript received June 11, 2007; revised manuscript received October 24, 2007,
ccepted November 8, 2007.tructural heart disease (1,2). On the other hand, ARVC/D
s a progressive, often inherited, cardiomyopathy character-
zed by right ventricular (RV) dysfunction due to fibrofatty
See page 740
eplacement of myocardium, which predisposes to ventric-
lar arrhythmias and sudden arrhythmic death, especially in
oung people and athletes (3–5). Although RVOT tachy-
ardia is considered benign and not progressive, it may cause
yncope and, uncommonly, sudden cardiac death (6–9).
hese rare malignant events are most likely explained by the
linical overlap between idiopathic RVOT tachycardia and
arly and/or segmental ARVC/D. Therefore, distinction
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RVOT Tachycardia February 19, 2008:731–9between patients with idiopathic
RVOT tachycardia and ARVC/D
is critical because it implies differ-
ent prognosis and management
strategies. Differential diagnosis,
however, may be challenging, es-
pecially in patients with ARVC/D
at its early stage or in its minor
variant, which is characterized by
clinically subtle myocardial abnor-
malities without evidence of
ventricular dilation/dysfunction
(1,4,5,10).
The hallmark pathological
lesion of ARVC/D is the trans-
mural loss of the myocardium
of the RV free wall with re-
placement by fibrofatty tissue
(3–5). Three-dimensional electro-
anatomical voltage mapping (EVM)
by CARTO system (Biosense-
Webster, Diamond Bar, Califor-
ia) has been demonstrated to reliably identify and charac-
erize low-voltage regions (“electroanatomical scar”) (11–
4), which in patients with ARVC/D correspond to areas of
yocardial depletion and correlate with the histopatholog-
cal finding of myocardial atrophy and fibrofatty replace-
ent at endomyocardial biopsy (EMB) (13).
The aim of the present study was to test whether EVM
ay help in the differential diagnosis between idiopathic
nd ARVC/D-related RVOT tachycardia by the identifi-
ation of otherwise concealed cardiomyopathic changes in
atients presenting with RVOT tachycardia and an appar-
ntly normal heart.
ethods
mong 89 consecutive patients with RVOT tachycardia
defined as monomorphic left bundle branch block pattern
nd inferior axis) and an apparently normal heart who were
eferred for catheter ablation between 2002 and 2005, 27
30%) underwent EVM and EMB to exclude an underlying
ubtle ARVC/D (see the following text) and are the subject
f this study. The study was approved by the institutional
eview board, and all patients gave their informed consent.
linical evaluation. In all patients cardiovascular evalu-
tion included history, physical examination, laboratory
ests, chest radiograph, 12-lead electrocardiogram (ECG)
ecording, 24-h Holter monitoring, signal averaged-
lectrocardiogram (SAECG), exercise testing, 2-dimen-
ional/color Doppler echocardiography, RV and left ven-
ricular (LV) cineagiography (in the right and left anterior
blique views), and coronary angiography. Technical equip-
ent, protocols, and reference values of each investigation
ave been reported in detail elsewhere (13). Quantitative
Abbreviations
and Acronyms
ARVC/D  arrhythmogenic
right ventricular
cardiomyopathy/dysplasia
CMR  cardiac magnetic
resonance
EMB  endomyocardial
biopsy
EVM  electroanatomical
voltage mapping
LV  left
ventricle/ventricular
RV  right
ventricle/ventricular
RVOT  right ventricular
outflow tract
SAECG  signal-averaged
electrocardiogram
VT  ventricular
tachycardiaV echocardiographic measurements were performed and “valuated according to Yoerger et al. (15). Patients were
udged as having a structurally normal heart on the basis of
ormal RV and LV cavity dimension and function, either
lobal or regional, as determined by echocardiography and
ardiac catheterization. No patients fulfilled the diagnostic
riteria for ARVC/D recommended by the European So-
iety of Cardiology/International Society and Federation of
ardiology Task Force (16).
haracterization of VT myocardial substrate. Although
he study patients had normal RV and LV cavity dimension
nd function, they underwent further evaluation through
VM and EMB because of 1 or more of the following
linical findings: family history of sudden death (n 
), pre-syncope (n  7), competitive athletic activity (n 
), QRS duration110 ms in right precordial leads (n 6),
ate potentials at SAECG (n  6), and inverted T waves in
nferior leads (n  4).
VM. All patients underwent detailed EVM by the
ARTO system (Biosense-Webster) during sinus rhythm,
s previously reported (11–14). In brief, a 7-F Navi-Star
Biosense-Webster) catheter, with a 4-mm distal tip elec-
rode and a 2-mm ring electrode with an interelectrode
istance of 1 mm, was introduced into the RV under
uoroscopic guidance and used as the mapping/ablation
atheter. The catheter was placed at multiple sites on the
ndocardial surface to record bipolar electrograms from RV
nflow, anterior free wall, apex, and outflow. Bipolar elec-
rogram signals (filtered at 10 to 400 Hz and displayed at
00 mm/s speeds on the CARTO system) were analyzed
ith regard to amplitude, duration, relation to the surface
RS, and presence of multiple components. A recording
as accepted and integrated into the map when the vari-
bility in cycle length, local activation time stability, and
aximum beat-to-beat difference of the location of the
atheter were 2%, 3 ms, and 4 mm, respectively.
hese parameters, combined with impedence measure-
ents, were used to exclude signals with low amplitude due
o poor endocardial catheter contact. In addition, adequate
atheter contact was confirmed by concordant catheter tip
otion with the cardiac silhouettes on fluoroscopy. Bipolar
oltage reference for normal and abnormal myocardium was
ased on values validated by intraoperative and catheter
apping (17,18) and used in previous voltage mapping
tudies (12–14,19,20).
The color display for depicting normal and abnormal
oltage myocardium ranged from “red” representing “elec-
roanatomical scar tissue” (amplitude 0.5 mV) to “purple”
epresenting “electroanatomical normal tissue” (amplitude
1.5 mV). Intermediate colors represented the “electroana-
omical border zone” (signal amplitudes between 0.5 and 1.5
V). Complete endocardial maps were obtained in all
atients to ensure reconstruction of a 3-dimensional geom-
try of the RV chamber and to identify scar regions. Regions
howing low-amplitude electrograms were mapped with
reater point density to delineate the extent and borders of
electroanatomical scar” areas.
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February 19, 2008:731–9 RVOT TachycardiaMB. All patients underwent EMB of the RV via the
emoral vein using the long sheath technique (Disposable
ordis Bioptome, Miami, Florida). The samples were ob-
ained under fluoroscopic guidance from the anterior RV free
all toward the ventricular septum (13,21), blindly of EVM
esults. Biopsy specimens were fixed in 10% phosphate-
uffered formalin (pH 7.35) and processed for histologic
xamination. Seven-micron-thick paraffin-embedded sections
ere serially cut and stained according to the hematoxylin-
osin and Heidenhain trichrome techniques. A mean of 2.9
.7 EMB samples per patient were available for investigation.
istopathological diagnosis of ARVC/D was put forward
ndependently by 2 observers (C.B., G.T.), blinded to EVM
esults, on the basis of a significant amount of myocardial
trophy and fibrofatty tissue replacement, which was evaluated
hrough histomorphometric analysis (21).
lectrophysiological study and catheter ablation. All an-
iarrhythmic drugs were discontinued 5 half-lives (6 weeks
or amiodarone) before the electrophysiological study. Pro-
rammed ventricular stimulation protocol included 3 drive-
ycle lengths (600, 500, and 400 ms) and 3 ventricular
xtrastimuli while pacing from 2 RV sites (apex and outflow
ract). In patients in whom VT was not inducible at
aseline, isoproterenol was administrated intravenously (2
o 6 g/min) and titrated so that the clinical VT or
epetitive monomorphic ventricular beats matching the
linical VT morphology occurred.
The site of origin of the ventricular arrhythmia was
stablished by activation mapping and/or pace mapping.
he activation map was created by mapping several points
ithin the RVOT during ventricular arrhythmias while
sing a surface ECG lead as a reference. Activation times
ere assigned on the basis of the onset of bipolar electro-
rams and displayed as color gradients on a 3-dimensional
ctivation map. A suitable target for ablation was selected
ased on the earliest endocardial activation times during
rrhythmia (or during episodes of frequent premature ventric-
lar beats with QRS morphology identical to the clinical
achycardia) and confirmed by the pace mapping that provided
11 of 12 matches between paced and spontaneous QRS
omplexes.
linical Characteristics of the Overall Sample and According to Re
Table 1 Clinical Characteristics of the Overall Sample and Acc
Clinical Characteristics
Overall Sample
(n  27)
Age (yrs) 33.9 8
Gender (male) 15 (55)
Family history of sudden death 3 (11)
Clinical symptoms 25 (92)
Pre-syncope 7 (26)
Palpitations 18 (72)
Competitive athletes 9 (33)
Interval between symptom onset and EVM (months) 35 8alues are expressed as n (%) or mean  SD.
EVM  electroanatomical voltage mapping.Sustained VTs inducible by programmed ventricular
timulation were entrained at cycle lengths of 20 to 40 ms
elow the cycle length of the tachycardia to guide the site of
blation. Substrate-based catheter ablation at sinus rhythm
as accomplished by creating linear ablation lesions encir-
ling and/or connecting RVOT electroanatomical scars,
ccording to a previously reported method (12,14). Ablation
as performed with a 4-mm tip ablation catheter using
adiofrequency energy (target temperature 60°C, maximal
ower 50 W) delivered for up to 60 s. The procedure was
onsidered acutely successful if ventricular arrhythmia was
bolished during ablation, remained absent for at least 30
in after ablation, and was not reinduced by either pro-
rammed ventricular stimulation or isoproterenol infusion.
tatistical analysis. Continuous variables are expressed as
ange and mean  standard deviation. Categorical differences
etween groups were evaluated by the Fisher exact text.
ifferences between group means were compared by unpaired
test. All probability values reported are 2-sided, and a
robability value 0.05 was considered to be statistically
ignificant.
esults
linical characteristics. Clinical characteristics, instru-
ental findings, and electrophysiological data are summa-
ized in Tables 1 to 3. The study population consisted of 27
atients (15 men and 12 women; age range 16 to 51 years;
ean age 33.9  8 years), 9 of whom were competitive
thletes. Three patients had a family history of premature
age 40 years) sudden death. Spontaneous ventricular
rrhythmias with a left bundle branch block/inferior axis
attern were documented in all patients and included
ustained monomorphic VT in 17 (Figs. 1 and 2) and
onsustained VT in 10. All 27 patients had normal LV and
V size and function, either global or regional, by echocar-
iography and angiography (Table 1). Seven patients un-
erwent cardiac magnetic resonance (CMR) as part of the
nitial clinical evaluation at their local hospital; 4 of these
57%) were reported to have abnormal findings consistent
ith a diagnosis of ARVC/D. In 6 of 27 patients (22%),
MB showed significant myocardial atrophy and fibrofatty
of Voltage Mapping
g to Results of Voltage Mapping
Normal EVM
Group A (n  20)
Abnormal EVM
Group B (n  7) p Value
33.6 6 34.1 3 0.91
12 (60) 3 (43) 0.66
2 (10) 1 (14) 1.0
19 (88) 6 (86) 0.46
4/19 (21) 3/6 (50) 0.30
15/19 (79) 3/6 (50) 0.30
7 (35) 2 (28) 1.0
35 9 36 4 0.9sults
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RVOT Tachycardia February 19, 2008:731–9eplacement consistent with ARVC/D; in the remaining 21
atients (78%), no histologic abnormalities, either inflam-
atory or degenerative, were found, and the EMB was
eported as normal (Figs. 1 and 2).
VM. Electroanatomical voltage mapping was successfully
cquired during sinus rhythm in all patients. The mean
umber of sites sampled in RV EVM was 187  29, with
n average mapping period of 28  7 min. Electroanatomi-
al voltage mapping was normal in 20 patients (74%) (group
), with preserved bipolar electrogram amplitude (5.1 0.8
V) and duration (36.9  6 ms) throughout the RV free
all and septum (Fig. 1). The remaining 7 patients (26%)
ad an abnormal RV EVM (group B) showing 1 area
mean 1.4  0.7), with bipolar electrogram voltage 0.5
V (i.e., electroanatomical scar tissue) (Fig. 2). Low-
oltage areas were sharply demarcated by a border zone with
nstrumental Findings of the Overall Sample and According to Resu
Table 2 Instrumental Findings of the Overall Sample and Accor
Overall Sample
(n  27)
Depolarization/conduction ECG abnormalities
QRS duration 110 ms (V1 to V2) 6 (22)
Late potential on SAECG 7 (26)
Repolarization abnormalities
Inverted T waves in V1 to V2/V3 0
Inverted T waves in inferior leads 4 (15)
Ventricular arrhythmias
Sustained VT 17 (63)
Nonsustained VT 10 (27)
Lead I QRS duration 120 ms during VT 14 (52)
Abnormal CMR 4/7 (57)
Echocardiographic findings
Echocardiographic RVEDA (cm2) 16.5 2.1
Echocardiographic RVOT-PLAX diastole (mm) 26.8 2.7
Angiographic findings
Angiographic RV ejection fraction 61 9
Angiographic RVED volume (ml/m2) 59 8
Fibrofatty myocardial replacement at EMB 6 (22)
alues are expressed as n (%) or mean  SD.
CMR  cardiac magnetic resonance; ECG  electrocardiogram; EMB  endomyocardial biop
VED  right ventricular end-diastolic; RVEDA  right ventricular end-diastolic area; RVOT  righ
lectrophysiological Findings of the Overall Sample and According
Table 3 Electrophysiological Findings of the Overall Sample an
Overall Sam
(n  27)
Programmed ventricular stimulation
VT inducibility 6 (22
Number of VT morphologies 1.3 0.5
Earliest endocardial activation of ventricular arrhythmias
in the nonseptal surface of RVOT
12 (44
VT cycle length (mean) (ms) 353 68
Acute success of catheter ablation 18/20 (90
Follow-up after mapping/ablation (months) 41 8
VT relapses 10/27 (37
ICD therapy (during follow-up) 3 (11alues are expressed as n (%) or mean  SD.
ICD  implantable cardioverter-defibrillator; other abbreviations as in Table 2.educed signal amplitudes (0.5 to 1.5 mV), which merged
nto normal myocardium (1.5 mV). Compared with
lectrograms sampled from unaffected areas, those recorded
rom within electroanatomical scar tissue showed lower
mplitude (0.3 0.09 mV vs. 4.7 0.6 mV) and prolonged
uration (76.7  18 ms vs. 37.3  8 ms; p  0.001) and
xtended beyond the offset of the surface QRS (66%; p 
.001). In 5 patients the electroanatomical scars were
onfined to the anteroinfundibular region, whereas in the
emaining 2 patients there were multiregional RV lesions,
hich also involved areas remote to RVOT such as the
nferobasal (2 patients) and the apical (1 patient) regions.
he ventricular septum was spared in all patients.
lectrophysiological studies and catheter ablation. Clinical
rrhythmia was reproduced in the electrophysiological lab-
ratory in all patients. Programmed ventricular stimulation
f Voltage Mapping
to Results of Voltage Mapping
Normal EVM
Group A (n  20)
Abnormal EVM
Group B (n  7) p Value
1 (5) 5 (71) 0.001
3 (15) 4 (57) 0.05
0 0 —
2 (10) 2 (28) 0.27
12 (60) 5 (71) 0.68
8 (40) 2 (29) 0.68
8 (40) 6 (86) 0.08
3/5 (60) 1/2 (50) 1.0
16.3 2.1 16.9 2.2 0.52
26.7 2.7 27.1 2.9 0.74
62 4 61 7 0.74
59 1 60 6 0.67
0 6 (86) 0.001
 electroanatomical voltage mapping; PLAX  parasternal long axis; RV  right ventricular;
ular outflow tract; SAECG  signal-averaged electrocardiogram; VT  ventricular tachycardia.
sults of Voltage Mapping
ording to Results of Voltage Mapping
Normal EVM
Group A (n  20)
Abnormal EVM
Group B (n  7) p Value
1 (5) 5 (71) 0.001
1 0 1.4 0.5 0.17
6 (30) 6 (86) 0.024
358 54 346 61 0.36
14/15 (93) 4/5 (80) 0.45
41 5 42 13 0.74
7 (35) 3 (43) 1.0
0 3 (43) 0.012lts o
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February 19, 2008:731–9 RVOT Tachycardianduced 1 or more sustained VT in 6 patients: overall 8
nduced morphologies with at least 1 identical to that
ecorded clinically. In the remaining 21 patients, clinical
rrhythmia was produced or worsened by isoproterenol
hallenge: 9 patients had isolated or coupled monomorphic
remature ventricular beats, 8 had nonsustained VT, and 4
ad sustained VT, which in each case matched the clinical
T morphology. Mean cycle length during VT was 353 
8 ms (range 240 to 470 ms).
Activation mapping and/or pace mapping showed that
entricular arrhythmia arose from the RVOT in each case:
nteroseptally in 12, anterolaterally in 9, posterolaterally in
, midposteroseptally in 2, and close to the His bundle in 1.
n all patients from group B, the best VT pace map was
btained from the RVOT sites of electroanatomical scars.
Although catheter ablation was considered in all patients,
t was actually attempted in 20 (74%), either because of
nsufficient ventricular ectopy (3 patients) or because the
atients refused the procedure (4 patients). In the 14
atients in whom clinical ventricular arrhythmia was only
nduced by isoproterenol infusion, the ablation was guided
Figure 1 Electrocardiographic and Histopathological Findings
in a Representative Patient From Group A
(A) Right anterior oblique view of the right ventricular (RV) bipolar voltage map
showing preserved bipolar voltages values (purple indicates 1.5 mV) through-
out the RV. (B) Endomyocardial biopsy sample showing normal myocardium
(Heidenhain trichrome 40). (C) 12-lead electrocardiogram during clinically-
sustained ventricular tachycardia 170 beats/min, with a left bundle branch
block/inferior axis morphology.y both activation and pace mapping. In the remaining 6atients with inducible and tolerated sustained VT, the
rrhythmia circuit was initially localized and ablated by
ctivation/entrainment mapping during VT. In 3 of these
atients, in whom sustained VT remained inducible after
lectrophysiological mapping-guided ablation, an alterna-
ive substrate-based ablation approach was attempted at
inus rhythm by isolating RVOT electroanatomical scars
nd connecting scar to scar and/or scar to the pulmonary
alve annulus (Fig. 3). A mean of 23  18 radiofrequency
esions was applied per patient. Acute success was achieved
n 18 of 20 (90%) patients.
During a mean follow-up period of 41 8 months, 17 of
7 patients remained free of VT. Ventricular tachycardia
ecurrence was documented in the remaining 10 patients: in
of 18 (17%) patients with successful catheter ablation and
n 7 of 9 patients (78%) either not undergoing catheter
blation (5 of 7, 71%) or undergoing an unsuccessful
rocedure (2 of 2, 100%). Three patients received an
mplantable defibrillator because of life-threatening VT
eading to either syncope (2 patients) or aborted sudden
eath (1 patient). The other 7 patients experienced hemo-
Figure 2 Electrocardiographic and Histopathological Findings
in a Representative Patient From Group B
(A) Right anterior oblique view of the right ventricular bipolar voltage map
showing a low-amplitude (red indicates 0.5 mV) area in the anteroinfundibu-
lar region. (B) Endomyocardial biopsy samples showing fibrofatty replacement
(Heidenhain trichrome 40). (C) 12-lead electrocardiogram during clinically-
sustained ventricular tachycardia 170 beats/min, with a left bundle branch
block/inferior axis morphology.
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RVOT Tachycardia February 19, 2008:731–9ynamically well-tolerated VT recurrences and continued to
eceive antiarrhythmic drug therapy and/or beta-blockers.
orrelation of results. Tables 1 to 3 show the comparison
etween patients with normal (group A) and abnormal
group B) EVM, with respect to a series of clinical,
lectrophysiological, and follow-up variables. Compared
ith patients from group A, those from group B signifi-
antly more often had a right precordial QRS duration
110 ms (p  0.001) and VT inducibility at programmed
entricular stimulation (p  0.001); late potentials on
AECG reached borderline statistical significance (p 
.05). The earliest site of endocardial activation during
linical ventricular arrhythmia occurred at the nonseptal
i.e., free wall) RVOT (rather than at the septal RVOT) in
of 20 (30%) patients from group A and in 6 of 7 (86%)
atients from group B (p  0.024). Right precordial QRS
uration 110 ms showed a sensitivity and a specificity in
redicting an abnormal EVM of 71% and 95%, respectively;
ate potential on SAECG of 57% and 85%, respectively; VT
nducibility at programmed ventricular stimulation of 71%
nd 95%, respectively; and nonseptal origin of VT of 86%
nd 70%, respectively.
Demonstration of RV electroanatomical scar showed a
tatistically significant correlation with histopathological ab-
ormalities at EMB: 6 of 7 patients from group B (86%)
howed myocardial atrophy and fibrofatty myocardial replace-
ent consistent with the diagnosis of ARVC/D (Fig. 2),
ompared with none of the 20 patients from group A (p 
.001). An abnormal EVM had 100% sensitivity and 95%
pecificity to identify patients with a positive EMB.
Three patients (55%) from group B received an implant-
ble defibrillator during the follow-up compared with no
Figure 3 3-Dimensional Electroanatomical Maps of the RV in 2
Representative Patients Undergoing Catheter Ablation
(Left) Voltage mapping (left anterior oblique [LAO] 60°) showing preserved bipolar
patient from group A. Red dots indicate the site of successful radiofrequency abla
Voltage mapping (right anterior oblique 30°) showing electroanatomical scar region
longer inducible only after completion of serial point ablations completely encirclinatients from group A (p  0.012). wiscussion
he major finding of the present study is that an early/
inor form of ARVC/D may present clinically as RVOT
achycardia in the absence of RV dilation/dysfunction, thus
imicking idiopathic RVOT tachycardia. Electroanatomi-
al voltage mapping is able to identify such concealed
RVC/D variants by detecting RV electroanatomical scars
hat correlate with the histopathological features pathogno-
onic of the disease.
VM. Electroanatomical voltage mapping by the CARTO
ystem has been recently demonstrated to reliably identify
nd characterize low-voltage regions (“electroanatomical
car”) (11–14), which in patients with ARVC/D correspond
o areas of myocardial depletion and correlate with the
istopathological finding of myocyte loss and fibrofatty
eplacement at EMB (13). The results of the present study
onfirm and extend these prior observations by indicating
hat EVM of the RV is a useful electrophysiological test for
istinguishing patients with idiopathic RVOT tachycardia
rom those with an underlying subtle ARVC/D. The
echnique provided evidence of electroanatomical RV
car(s) in a subset of patients with RVOT tachycardia,
espite a normal RV size and function at echocardiography/
ngiography. The majority of patients with an abnormal
VM had electroanatomical scars confined to anteroinfun-
ibular free wall; only 2 patients showed multiregional RV
cars also involving remote regions of the so-called “triangle
f dysplasia” such as the inferobasal or the apical areas. In
ur study, the segmental nature of RV lesions with predom-
nant involvement of the free wall of the RVOT may explain
VOT Tachycardia
grams amplitude throughout the right ventricular (RV) free wall and septum in a
the anteroseptal surface of the right ventricular outflow tract (RVOT). (Right)
e RVOT in a patient from group B. Targeted ventricular tachycardia was no
s of abnormal voltages.of R
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February 19, 2008:731–9 RVOT Tachycardiand ejection fraction. This is in keeping with previous
tudies showing that some patients with localized
RVC/D, particularly in the infundibulum, may exhibit
ormal RV volumes and preserved RV ejection fraction at
ngiography (13). Moreover, it is problematic to detect by
urrent imaging techniques segmental ventricular lesions
ocalized to the RVOT and RV anterior free wall (22,23). A
ecent angiographic study of computer-based quantitative
egmental contraction analysis of the RV free wall demon-
trated that wall motion is nonuniform in different RV
egions: tricuspid valve zones show the greatest movement
uring contraction, whereas anterior and infundibular re-
ions the least movement (24). In the present study, we
emonstrated that EVM, by assessing the electrical rather
han the mechanical effects of loss of RV myocardium,
bviated limitations in RVOT wall motion analysis and
ncreased the sensitivity for detecting otherwise concealed
RVC/D myocardial substrate. This is in agreement with
revious data on EVM in ARVC/D patients indicating that
V electroanatomical scars may be demonstrated in the
bsence of detectable wall motion abnormality (13).
MB. Prior studies on EMB in patients with RVOT
achycardia resulted in contradictory findings, most likely
ecause of patient selection bias (2,25,26). In our study,
brofatty myocardial replacement at EMB was distinctively
emonstrated in patients with RV electroanatomical scar.
his is in agreement with a previous study in ARVC/D
atients showing a strong association between abnormal
oltage map and histopathological alterations (13). Demon-
tration of fibrofatty myocardial replacement on EMB is
onsidered a major criterion for diagnosis of ARVC/D in
he European Society of Cardiology/International Society
nd Federation of Cardiology Task Force guidelines (16).
his substantiates the RV EVM findings and supports the
onclusion that RVOT tachycardia in this patient subgroup
ccurred in the context of ARVC/D.
revious studies. Boulos et al. (27) previously compared
lectroanatomical findings in patients with an ultimate
iagnosis of idiopathic RVOT tachycardia with those in
atients who had established ARVC/D. They found that
apping results were in concordance with previous clinical
iagnosis, by showing normal voltages in the idiopathic
VOT tachycardia group and abnormal low-amplitude
reas in ARVC/D patients. However, in this investigation a
istologic study to validate the clinical diagnosis was not
one. Our study was designed to evaluate the accuracy of
VM to detect an otherwise concealed electroanatomical
ubstrate in a series of patients referred for catheter ablation
f RVOT tachycardia, in the absence of RV dilation/
ysfunction. Besides the different study design, discrepancy
etween the 2 investigations may be explained by different
ap density. Acquired voltage maps in the present study
ad a significantly higher density than that obtained in the
oulos et al. (27) study, with average sampled points of
87  16 versus 97  9, respectively. vSeveral previous studies have demonstrated that CMR
etects ARVC/D-like structural and wall motion abnor-
alities in a high proportion of patients with RVOT
achycardia (28 –30). However, the clinical and prognos-
ic significance of such findings is uncertain, because of
everal limitations and a high degree of interobserver
ariability in the CMR evaluation of the RV. Particularly,
MR has been implicated in overdiagnosis of ARVC/D
ased on the finding that free-wall thinning and in-
reased intramyocardial fat as well as global or regional
V dysfunction are also evidenced in healthy subjects
31,32). A recent CMR study focused on RV wall motion
attern in normal subjects reported the presence of wall
otion abnormalities in 93.1% of them, including areas
f apparent dyskinesia in 75.9% and bulging in 27.6%
33). All these data indicate that conventional CMR may
urther confuse differential diagnosis between idiopathic
VOT tachycardia and ARVC/D by showing equivocal
V structural and functional abnormalities.
blation therapy. Previous studies showed the good acute
uccess rate of catheter ablation of RV tachycardia, either
diopathic (1,10,28,29) or associated with ARVC/D
12,14,34,35). However, in patients with ARVC/D, VT
ecurrences are common (up to 60% of the cases) and may
ead to sudden death. The discrepancy between the good
cute results and the unfavorable long-term outcome may be
xplained by the progressive nature of ARVC/D, which
redisposes to the occurrence of new and malignant ar-
hythmogenic substrates over time (34). Accordingly, in our
tudy, the short-term success of catheter ablation did not
iffer between patients with normal and those with abnor-
al EVM (85% vs. 89%). However, 3 patients with evi-
ence of RV electroanatomical scar experienced life-
hreatening VT during follow-up (despite previously
uccessful catheter ablation in 2 patients) and required
mplantable cardioverter-defibrillator therapy, compared
ith none of patients with normal EVM. These findings
ndicate that the subset of patients with RVOT tachycardia
nd electroanatomical evidence of RV scar tend toward a
orse clinical outcome with an increased risk of sudden
rrhythmic death.
otential study limitations. The study population com-
rised a selected subset of patients with RVOT tachycardia
nd normal RV/LV function, who underwent further eval-
ation because of suspicious clinical findings. The preva-
ence of ARVC/D-related RVOT tachycardia might not be
o high in an unselected group of patients with RVOT
achycardia. The unusually high percentage of competitive
thletes is explained by the Italian pre-participation evalu-
tion unmasking athletes with ventricular arrhythmias. In
atients with ARVC/D, mechanical stress such as that
ccurring during training and sports competition may exert
dverse effects by worsening myocyte death and triggering
entricular arrhythmias (3–5,9).
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linical implications. We demonstrated that some pa-
ients with RVOT tachycardia in the absence of RV
ilation/dysfunction show RVOT electroanatomical scars in
ssociation with histopathological features pathognomonic
f ARVD/C (i.e., fibrofatty myocardial replacement) and
ave a malignant arrhythmic course. These findings are
onsistent with the current perspective on the ARVC/D
atural history, with an early “concealed” phase character-
zed by subtle RV structural changes, which may be con-
ned to 1 region of the so-called triangle of dysplasia, and,
evertheless, predispose to ventricular tachyarrhythmias or
udden death (4,5). This supports the conclusion that our
atients from group B had a segmental form of ARVC/D
ather than an idiopathic RVOT tachycardia with a non-
pecific focal myocardial damage.
Clinical predictors of RV electroanatomical scars were
RS prolongation in the leads exploring the RVOT, late
otentials, VT inducibility at programmed ventricular stim-
lation, and VT origin from the nonseptal RVOT. A
orollary is that the clinical finding of increased right
recordial QRS duration and/or late potentials in patients
resenting with RVOT tachycardia should raise the suspi-
ion of a concealed ARVC/D, even in the presence of
ormal ventricular size and function. Electrophysiological
tudy may be of limited value in the differential diagnosis
etween idiopathic and ARVC/D-related RVOT tachycar-
ia because a proportion of patients with spontaneous VT
re not inducible regardless of the underlying substrate and
ecause idiopathic VT not rarely originates from nonseptal
VOT. Right ventricular EVM, in addition to conven-
ional electrophysiological study, offers the potential to
irectly identify RVOT electroanatomical scars, which are
ighly predictive of histopathological fibrofatty myocardial
eplacement (sensitivity of 100% and specificity of 95%).
ccordingly, further investigation by EMB should be re-
erved to selected cases in which clinical, electrophysiolog-
cal, and electroanatomical findings are inconclusive and
istologic validation of myocardial substrate is necessary to
chieve a definitive differential diagnosis.
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